Programing Cells in a Predictable and Scalable Way

The Bio Report - A podcast by Levine Media Group - Wednesdays

Categories:

Mark Kotter, founder and CEO of Bit.Bio, discusses the company’s platform technology, its effort to develop cell therapies, and its growing offering of precision reprogramed human cells for drug development.